A. Antigüedad

发表

Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease

A. Deutschländer, A. Alcina, F. Matesanz, 2019, PLoS genetics.

The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis

F. Matesanz, X. Montalban, M. Hecker, 2020, Cells.

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients

A. Goris, A. Alcina, F. Matesanz, 2016, G3: Genes, Genomes, Genetics.

MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.

M. Ban, S. Sawcer, A. Compston, 2013, Brain : a journal of neurology.

An Overground Robotic Gait Training Program for People With Multiple Sclerosis: A Protocol for a Randomized Clinical Trial

J. Irazusta, M. Domercq, I. Bidaurrazaga-Letona, 2020, Frontiers in Medicine.

The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis

A. Alcina, F. Matesanz, X. Montalban, 2010, Genes and Immunity.

[Study of inter-observer reliability in the use of qualitative scales assessing Parkinson disease (II)].

P. Martínez-Martín, F. Bermejo, C. Ramo, 1988, Archivos de neurobiologia.

[Inter-observer reproducibility of qualitative scales in Parkinson disease (I)].

P. Martínez-Martín, F. Bermejo, C. Ramo, 1987, Archivos de neurobiologia.

Identi ﬁ cation of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis

M. M. Abad-Grau, A. Alcina, F. Matesanz, 2012 .

Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects

Isabelle Cournu-Rebeix, Frauke Zipp, Ulman Lindenberger, 2012, Journal of Medical Genetics.

Genome-wide significant association with seven novel multiple sclerosis risk loci

A. Alcina, F. Matesanz, X. Montalban, 2015, Journal of Medical Genetics.

Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis

A. Alcina, F. Matesanz, E. Urcelay, 2014, PloS one.

Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

X. Montalban, E. Urcelay, K. Vandenbroeck, 2012, Journal of Neuroimmunology.

Polymorphisms in the interleukin‐4 and IL‐4 receptor genes and multiple sclerosis: a study in Spanish‐Basque, Northern Irish and Belgian populations

A. Goris, K. Vandenbroeck, I. Alloza, 2005, International journal of immunogenetics.

Neuromyelitis optica spectrum disorders

X. Montalban, P. Villoslada, L. Ramió-Torrentá, 2016, Neurology: Neuroimmunology & Neuroinflammation.

ANKRD55 and DHCR7 are novel multiple sclerosis risk loci

A. Alcina, F. Matesanz, X. Montalban, 2011, Genes and Immunity.

Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study

X. Montalban, J. Lechner-Scott, M. Slee, 2016, The Pharmacogenomics Journal.

A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis.

María M. Abad-Grau, Víctor Potenciano, M. M. Abad-Grau, 2015, Human molecular genetics.

A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis

A. Alcina, F. Matesanz, X. Montalban, 2011, Genes and Immunity.

Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6

A. Alcina, F. Matesanz, J. Oksenberg, 2013, PloS one.

Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain

A. Alcina, F. Matesanz, E. Urcelay, 2010, Journal of Neuroimmunology.

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes

A. Alcina, F. Matesanz, X. Montalban, 2012, Multiple sclerosis.

Replication of top markers of a genome-wide association study in multiple sclerosis in Spain

A. Alcina, F. Matesanz, X. Montalban, 2011, Genes and Immunity.

Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS)

J. Benito-León, P. Martínez-Martín, J. Ruiz‐Martinez, 2007, Multiple sclerosis.

Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis

María M. Abad-Grau, M. M. Abad-Grau, A. Alcina, 2012, Journal of Medical Genetics.

Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk

Shu-Chen Li, A. Alcina, F. Matesanz, 2013, Journal of Medical Genetics.

Monitoring response to disease-modifying treatment in multiple sclerosis

J. Río, C. Oreja-Guevara, R. Arroyo, 2023, Neurology Perspectives.

Recommendations for the clinical use of motor evoked potentials in multiple sclerosis

X. Montalban, P. Villoslada, J. Valls-Solé, 2013 .

[Recommendations for the clinical use of motor evoked potentials in multiple sclerosis].

X. Montalban, P. Villoslada, J. Valls-Solé, 2013, Neurologia.

Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection

E. Urcelay, K. Vandenbroeck, I. Alloza, 2011, Genes and Immunity.

Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells

C. Lindskog, X. Montalban, K. Vandenbroeck, 2022, Frontiers in Immunology.

Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain

A. Alcina, F. Matesanz, E. Urcelay, 2010, Journal of Neuroimmunology.